You are here
Articles on Gastrointestinal Cancer
A selection of peer-reviewed articles on Gastrointestinal Cancer. All content available on the Advances in Gastrointestinal Cancer Resource Center, including original and review articles, interviews, guidelines and congress highlights, is independently selected by the members of the Editorial Board.
Characterising timing and pattern of relapse following surgery for localised oesophagogastric adenocarcinoma: a retrospective study
Moorcraft SY, Fontana E, Cunningham D, Peckitt C, Waddell T, Smyth EC, et al.BMC Cancer. 2016 Feb 17;16(1):112.
Ilson DH.J Clin Oncol. 2016 Feb 16. [Epub ahead of print]
Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma
Pohl H, Pech O, Arash H, Stolte M, Manner H, May A, et al.Gut. 2016 Feb;65(2):196-201
Giandomenico Roviello, Andrea Ravelli, Karol Polom, Roberto Petrioli, Luigi Marano, Daniele Marrelli, Franco Roviello, Daniele Generali
Cancer Letters, Volume 372, Issue 2, March 2016, Pages 187 - 191
Systemic therapy beyond first-line in advanced gastric cancer: An overview of the main randomized clinical trials
Salvatore Galdy, Chiara Alessandra Cella, Francesca Spada, Sabina Murgioni, Anna Maria Frezza, Simona Paola Ravenda, Maria Giulia Zampino, Nicola Fazio
Critical Reviews in Oncology/Hematology, In Press, Corrected Proof, Available online 30 November 2015, Available online 30 November 2015
Exclusion of Gastrointestinal Cancer Patients With Prior Cancer From Clinical Trials: Is This Justified?
Elizabeth C. Smyth, Noelia Tarazona, Clare Peckitt, Edward Armstrong, Sonia Mansukhani, David Cunningham, Ian Chau
Clinical Colorectal Cancer, In Press, Corrected Proof, Available online 27 November 2015, Available online 27 November 2015
Quality-of-life and performance status results from the phase 3 RAINBOW study of ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated gastric or gastroesophageal junction adenocarcinoma
Al-Batran SE, Van Cutsem E, Cheul Oh S, Bodoky G, Shimada Y, Hironaka S, et al.Ann Oncol. 2016 Jan 7 [Epub ahead of print]
Serum HER2 as an adjunct to assess HER2 status for advanced gastric cancer: A prospective multicenter trial (SHERLOCK)
Saito M, Yamashita K, Arimura Y, Kaneto H, Okuda H, Nojima M, et al.Acta Oncol. 2016 Jan 12:1-9. [Epub ahead of print]
Prognostic value of neutrophil to lymphocyte ratio in advanced oesophago-gastric cancer: exploratory analysis of the REAL-2 trial
Grenader T, Waddell T, Peckitt C, Oates J, Starling N, Cunningham D, Bridgewater J.Ann Oncol. 2016 Jan 19 [Epub ahead of print]